VeriMom¿Es nicotinamide mononucleotide seguro durante el embarazo?
No harmonised CLP classification (ECHA Annex VI) or CIR/SCCS reproductive warnings were identified for nicotinamide mononucleotide. Authoritative cosmetic safety assessments (CIR/SCCS) do not list NMN as a reproductive hazard, and PubChem/ECHA registration summaries do not report harmonised reproductive classifications. Peer-reviewed literature on NMN focuses on metabolic and ageing effects rather than teratogenicity, with no confirmed human reproductive risk reported.
Related ingredients
Frequently asked questions
- ¿Es nicotinamide mononucleotide seguro durante el embarazo?
- No harmonised CLP classification (ECHA Annex VI) or CIR/SCCS reproductive warnings were identified for nicotinamide mononucleotide. Authoritative cosmetic safety assessments (CIR/SCCS) do not list NMN as a reproductive hazard, and PubChem/ECHA registration summaries do not report harmonised reproductive classifications. Peer-reviewed literature on NMN focuses on metabolic and ageing effects rather than teratogenicity, with no confirmed human reproductive risk reported.
- ¿Es nicotinamide mononucleotide seguro durante la lactancia?
- No regulatory or authoritative sources (ECHA Annex VI, CIR, SCCS) identify NMN as a lactation/breastfeeding hazard. There is no evidence of human breastmilk transfer or lactation-specific adverse effects in available summaries; no harmonised classification for reproductive/lactation toxicity exists.
- ¿Es nicotinamide mononucleotide seguro para la piel del bebé?
- Hazard and mechanism: no infant-specific reproductive or endocrine hazards identified in authoritative sources. Exposure: NMN is a small, hydrophilic NAD+ precursor (not a highly lipophilic, high-penetration molecule); dermal absorption from topical use is expected to be low in adults, but per instruction infant exposure score is increased by +1 to account for higher surface-area-to-weight and immature barrier, giving a low but measurable exposure for 0–3 yr skin.
- ¿Cómo puntúa VeriMom a nicotinamide mononucleotide?
- VeriMom puntúa nicotinamide mononucleotide en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a nicotinamide mononucleotide en el embarazo?
- Consulta nuestra lista de alternativas seguras a nicotinamide mononucleotide según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.